Rupert Handgretinger

33.5k total citations · 3 hit papers
493 papers, 19.0k citations indexed

About

Rupert Handgretinger is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Rupert Handgretinger has authored 493 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 204 papers in Hematology, 191 papers in Immunology and 158 papers in Oncology. Recurrent topics in Rupert Handgretinger's work include Hematopoietic Stem Cell Transplantation (187 papers), Immune Cell Function and Interaction (133 papers) and CAR-T cell therapy research (85 papers). Rupert Handgretinger is often cited by papers focused on Hematopoietic Stem Cell Transplantation (187 papers), Immune Cell Function and Interaction (133 papers) and CAR-T cell therapy research (85 papers). Rupert Handgretinger collaborates with scholars based in Germany, United States and Austria. Rupert Handgretinger's co-authors include Peter Lang, D. Niethammer, Michael Schumm, Tobias Feuchtinger, Peter Bader, Ingo Müller, Nicolas Sévenet, Olivier Delattre, Thomas Klingebiel and Wing Leung and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

Rupert Handgretinger

484 papers receiving 18.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Lymphoid and Myeloid Cell Development in NOD/LtSz- scid IL2R γ null Mice Engrafted with Mobilized Human Hemopoietic Stem Cells,

2005 1.3k citations Stephen D. Gillies, Rupert Handgretinger et al. profile →
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1998 1.1k citations Rupert Handgretinger et al. profile →
Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

2011 594 citations Rupert Handgretinger et al. profile →

Peers

Countries citing papers authored by Rupert Handgretinger

Since Specialization

Citations

This map shows the geographic impact of Rupert Handgretinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Handgretinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Handgretinger more than expected).

Fields of papers citing papers by Rupert Handgretinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupert Handgretinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Handgretinger. The network helps show where Rupert Handgretinger may publish in the future.

Co-authorship network of co-authors of Rupert Handgretinger

This figure shows the co-authorship network connecting the top 25 collaborators of Rupert Handgretinger. A scholar is included among the top collaborators of Rupert Handgretinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupert Handgretinger. Rupert Handgretinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Double Filtration Plasmapheresis for Environmental Toxin Removal: A Case Series of Patients With Hyperlipoproteinemia(a) 2025 ·Journal of Clinical Apheresis ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stefano De Benedetti, (unknown), (unknown), (unknown), (unknown), (unknown), Yannick P. Kok, Rupert Handgretinger, Stefan R. Bornstein	0
2	Application of the National Comprehensive Cancer Network-distress thermometer in pediatric patients during autologous and allogeneic hematopoietic stem cell transplantation and relationship to blood parameters of the stress axis 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Peter Lang, Rupert Handgretinger, Jennifer Svaldi, Michaela Döring	2
3	CRISPR medicine for blood disorders: Progress and challenges in delivery 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Justin S. Antony, Rupert Handgretinger, Markus Mezger	8
4	A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease 2022 ·Transplantation and Cellular Therapy ·Carrie L. Kitko, Hisham Abdel‐Azim, Paul A. Carpenter, Jean‐Hugues Dalle, Cristina Díaz de Heredia, Stefania Gaspari, Andrew R. Gennery, Rupert Handgretinger, Ánita Lawitschka	7
5	Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency 2021 ·Genes ·(unknown), (unknown), (unknown), (unknown), Karin Schilbach, (unknown), Derya Güngör, (unknown), Elke Malenke, Justin S. Antony, Rupert Handgretinger, Markus Mezger	8
6	Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD 2021 ·Bone Marrow Transplantation ·Hisayoshi Hashimoto, (unknown), (unknown), (unknown), Hans‐Jörg Bühring, Rupert Handgretinger, Karin Schilbach	8
7	G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients 2019 ·British Journal of Haematology ·Corina Schneidawind, (unknown), (unknown), Michael Schumm, Rupert Handgretinger, Christoph Faul, Lothar Kanz, Wolfgang Bethge, Dominik Schneidawind	20
8	<p>Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies</p> 2019 ·Drug Design Development and Therapy ·(unknown), Martin Ebinger, Ulrike Hartmann, Manon Queudeville, Judith Feucht, Michael C. Ost, (unknown), (unknown), Markus Mezger, (unknown), Simone Schneider Weber, (unknown), (unknown), Peter Lang, Rupert Handgretinger, Michaela Döring	6
9	Fast enzymatic synthesis of n.c.a. 6‐[¹⁸F]fluorodopamine (FDA) from n.c.a. 6‐[¹⁸F]FDOPA and the fate of 6‐FDOPA and 6‐FDA in neuroblastoma and Caki‐1 cells after their uptake 2019 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Zyrafete Kuçi, Walter Ehrlichmann, Jörg Sauer, Rupert Handgretinger, Gernot Bruchelt, Gerald Reischl	3
10	Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo 2017 ·OncoImmunology ·Franziska Eckert, Ivan Jelas, (unknown), Stephan M. Huber, (unknown), (unknown), Stephen D. Gillies, Wolfgang Strittmatter, Daniel Zips, Rupert Handgretinger, Karin Schilbach	41
11	Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium—Haplo2014, San Francisco, California, December 4, 2014 2016 ·Biology of Blood and Marrow Transplantation ·Monzr M. Al Malki, Mary M. Horowitz, Rupert Handgretinger, Wing Leung, Denis-Claude Roy, Xiao‐Jun Huang, Ephraim J. Fuchs, Franco Locatelli, Didier Blaise, Shin Mineishi, Maria Paola Martelli, Jeffrey S. Miller, Carl H. June, (unknown), Leo Luznik, Domenico Mavilio, Enrico Lugli, Marcel R.M. van den Brink, Richard E. Champlin, Stefan O. Ciurea	7
12	Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia 2012 ·Blood ·Wing Leung, Ching‐Hon Pui, Elaine Coustan‐Smith, Jie Yang, Deqing Pei, Kwan Gan, Ashok Srinivasan, Christine Hartford, Brandon M. Triplett, Mari Dallas, Asha Pillai, David Shook, Jeffrey E. Rubnitz, John T. Sandlund, Sima Jeha, Hiroto Inaba, Raul C. Ribeiro, Rupert Handgretinger, Joseph Laver, Dario Campana	132
13	Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling 2012 ·Blood ·Stefanie Bugl, Stefan Wirths, Markus P. Radsak, Hansjörg Schild, Pamela Stein, Maya C. André, Martin Müller, Elke Malenke, Tina Wiesner, Melanie Märklin, Julia-Stefanie Frick, Rupert Handgretinger, Hans‐Georg Rammensee, Lothar Kanz, Hans‐Georg Kopp	78
14	Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group 2008 ·Journal of Clinical Oncology ·Peter Bader, Hermann Kreyenberg, Günter Henze, Cornelia Eckert, (unknown), André Willasch, Andrea Barth, Arndt Borkhardt, Christina Peters, Rupert Handgretinger, Karl‐Walter Sykora, Wolfgang Holter, H. Kabisch, Thomas Klingebiel, Arend von Stackelberg	252
15	Pure red cell aplasia 2000 ·British Journal of Haematology ·Paul Fisch, Rupert Handgretinger, Hans‐Eckart Schaefer	151
16	Pure red cell aplasia 2000 ·British Journal of Haematology ·Paul Fisch, Rupert Handgretinger, Hans‐Eckart Schaefer	67
17	Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS Device 1999 ·Journal of Hematotherapy ·Michael Schumm, Peter Lang, (unknown), Selim Kuçi, Thomas Klingebiel, Hans‐Jörg Bühring, A Geiselhart, D. Niethammer, Rupert Handgretinger	113
18	Positive Selection and Transplantation of Peripheral CD34+ Progenitor Cells: Feasibility and Purging Efficacy in Pediatric Patients with Neuroblastoma 1997 ·Journal of Hematotherapy ·Rupert Handgretinger, Johann Greil, (unknown), Peter Lang, Oscar González‐Ramella, Iris Schmidt, Russell Fuhrer, D. Niethammer, T. Klingebiel	36
19	Autologous Transplantation with Peripheral Blood Stem Cells in Children and Young Adults After Myeloablative Treatment: Nonrandomized Comparison Between GM-CSF and G-CSF for Mobilization 1995 ·Journal of Hematotherapy ·Thomas Klingebiel, Rupert Handgretinger, (unknown), (unknown), Peter Bader, Peter Lang, R. Dopfer, (unknown), Ulrike Haus, D. Niethammer	13
20	In Vitro and In Vivo Effect of Interleukin-2 on the 2′,5′-Oligoadenylate Synthetase Activity of Peripheral Mononuclear Blood Cells 1990 ·Journal of Interferon Research ·Rupert Handgretinger, Gernot Bruchelt, Astrid Kimmig, (unknown), (unknown), R. Dopfer, J. Treuner, D. Niethammer	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact